Two Sigma Advisers »

BioCryst Pharmaceuticals shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2012-09-30 $45k 11k 4.29
2012-06-30 $67k 17k 4.01

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Merck & Co (MRK)
Micron Technology (MU)
Netflix (NFLX)
Paypal Holdings (PYPL)
Bristol Myers Squibb (BMY)
Qualcomm (QCOM)
Pinterest Cl A (PINS)
Meta Platforms Cl A (META)
General Motors Company (GM)

View all positions for Two Sigma Advisers

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Braidwell
Kynam Capital Management
Deerfield Management Company
Fisher Investments
Two Sigma Investments
Jennifer Ranahan
Two Sigma Advisers
Millennium Management
Norges Bank Investment Management
Rice Hall James & Associates
Balyasny Asset Management
Stifel Financial

View all funds holding BioCryst Pharmaceuticals